The Department of Pharmaceuticals (DoP), Ministry of Chemicals & Fertilizers, Government of India, in collaboration with the Federation of Indian Chambers of Commerce and Industry (FICCI) and the Indian Pharmaceutical Alliance (IPA), will host the 9th edition of India Pharma 2026 on April 13–14, 2026, at Federation House, New Delhi.
As one of the most significant gatherings in the pharmaceutical sector, India Pharma 2026 will bring together global industry leaders, policymakers, researchers, and innovators to discuss the future of life sciences and healthcare innovation.
Theme: Discover in India – Leapfrogging Life-Sciences Innovation
As per the press release, this year’s theme, “Discover in India: Leapfrogging Life-Sciences Innovation,” reflects the country’s ambition to position itself as a global hub for pharmaceutical research, innovation, and advanced healthcare solutions.
By focusing on transformative scientific advancements, the event aims to showcase how innovation in life sciences can improve healthcare accessibility, accelerate economic growth, and strengthen global health security.
Strengthening India’s Position as the “Pharmacy of the World”
India has long been recognised as the “Pharmacy of the World” for supplying affordable, high-quality medicines to countries across the globe. Building on this reputation, India Pharma 2026 will focus on the next phase of growth for the sector.
Importantly, the event seeks to accelerate the transition of the Indian pharmaceutical industry from a volume-driven manufacturing model to a value- and innovation-driven global powerhouse. Through discussions and collaborations, stakeholders will explore strategies to expand research capabilities, strengthen supply chains, and enhance regulatory frameworks.
Showcasing Manufacturing Excellence and R&D Capabilities
In addition, the initiative will highlight India’s world-class pharmaceutical manufacturing ecosystem and rapidly expanding research and development landscape. The event will provide a platform for meaningful dialogue on drug discovery, complex generics, biosimilars, and emerging technologies shaping the future of healthcare.
By facilitating partnerships between government bodies, pharmaceutical companies, biotech firms, and research institutions, India Pharma 2026 aims to encourage innovation-led growth and strengthen India’s leadership in the global pharmaceutical market.
A Platform for Global Collaboration
Ultimately, India Pharma 2026 will serve as a strategic platform to promote international collaboration, attract investments, and support cutting-edge research in the life-sciences sector. Through keynote sessions, panel discussions, and networking opportunities, participants will explore pathways to advance healthcare innovation and expand India’s role in the global pharmaceutical ecosystem.